One-third of Patients Denied New Hepatitis C Drugs One-third of Patients Denied New Hepatitis C Drugs

Despite an overall greater availability of direct-acting antivirals, absolute denials by insurers increased during 2016-2017 and remained high regardless of insurance type.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news